π•π•šπ•£π•’π• π•π•’π•”π•”π•šπ•Ÿπ•– 𝕑𝕒𝕑𝕖𝕣 𝔹𝕒π•₯𝕔𝕙-π••π•–π•‘π•–π•Ÿπ••π•–π•Ÿπ•₯ 𝕀𝕒𝕗𝕖π•₯π•ͺ 𝕠𝕗 π•₯𝕙𝕖 π”Ήβ„•π•‹πŸ™πŸžπŸšπ•“πŸš π•žβ„β„•π”Έ ℂ𝕆𝕍𝕀𝔻-πŸ™πŸ‘ π•§π•’π•”π•”π•šπ•Ÿπ•–

71% of the suspected adverse reactions occurred in 4.2% of the vaccine batches Numbers of suspected adverse events (SAEs), after BNT612b2 mRNA vaccination in Denmark. 27 December 2020–11 January 2022, (population 5.8 million) (According to the number of doses per vaccine batch)

Each dot represents a single vaccine batch. By 11 November 2022 (European area) 701 million doses of Pfizer given 971,021 reports of suspected adverse effects (SAEs) Clinical data on individual vaccine batch levels have not been reported (batch-dependent variation in the clinical efficacy and safety of authorized vaccines would appear to be highly unlikely)

We therefore examined rates of SAEs between different BNT162b2 vaccine batches administered in Denmark Data on all SAE cases, Danish Medical Agency (DKMA) SAE seriousness was classified as non-serious, serious..

Source-Pfizer will explain this

Leave a Reply

Your email address will not be published. Required fields are marked *